Clearside Biomedical Submits Voluntary Chapter 11 Bankruptcy Petition
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 24 2025
0mins
Source: NASDAQ.COM
Bankruptcy Filing: Clearside Biomedical, Inc. has filed a voluntary petition for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.
Asset Sale Process: The company plans to seek court approval for an auction and sale process under Section 363 of the U.S. Bankruptcy Code, allowing interested parties to submit binding offers for its assets.
Operational Continuity: Clearside has filed motions to ensure that normal operations continue during the bankruptcy process.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
